Present and future etiological treatment of bacterial pneumonia 3. The antibacterial drugs under development

The rapid spread of antibiotic-resistant bacterial strains necessitates the development of new antibacterial agents and a review of the guidelines for etiological treatment of bacterial infections, including pneumonia. Currently, new antibacterial agents are being developed that disrupt the biosynthesis of peptidoglycan, teichoic and lipoteichoic acids, and also block the attachment of virulent factors to the bacterial wall. New molecules of old classes of antibiotics and representatives of new classes of antibiotics with their targets (lipid II and III, teichoic and lipoteichoic acids, alanine racemase, and sortase A) will become practical tools in clinical practice in the very near future. The goals and mechanisms of action of new antibacterial compounds predetermine their clinical prospects in future strategies for the treatment of infectious bacterial diseases

Genetic Polymorphism of Toll-like Receptor 4 — Predictor of Susceptibility to Recurrent Course of Chronic Pyelonephritis in Children

Objective of investigation: to study the role of Toll-like receptor 4 Asp299Gly gene polymorphism in the implementation of susceptibility to chronic pyelonephritis, to analyze its association with the major manifestations of the disease and to assess the impact on the synthesis of interleukin-6 in the blood of sick children. Methods. We examined a group of children aged 1–15 years with chronic pyelonephritis in the active stage (n = 60). Control group consisted of 95 apparently healthy people. Results. There were revealed significantly higher prevalence of Toll-like receptor 4 Asp299Gly gene polymorphism among children with chronic pyelonephritis (n = 60), identified a statistically significant correlation of mutant genotypes Asp299Gly, Gly299Gly with manifestation of the disease before the age of 3, and frequent episodes of acute respiratory viral infections, torpid urinary syndrome, unstable remission and increased secretion of interleukin-6 (p < 0.001). Thus, genetically determined Toll-like receptor 4 Asp299Gly gene polymorphism is a marker of high risk of early manifestation of chronic inflammation in the kidney interstitium and prolonged recurrent clinical course of the disease in children

Child health status — the future of the country (part 2)

The article deals with the problems of increasing the incidence and prevalence of childhood diseases during 1994–2016 against the background of a global reduction in the staffing of children’s specialists by 1.7 times, with an extremely inadequate supply of the regions of the South-East, Donetsk and Luhansk regions. All of this has a negative impact on the proper medical care of the child population, including the detection of childhood diseases. The authors substantiate the need to restore the personnel and material-technical potential of the pediatric service, the development of modern diagnostic and treatment technologies, the preservation of immunization and the prevention of disability of common childhood diseases that is an important component of the national health care and safety system of the country as a whole